Pfizer 2011 Annual Report Download - page 56

Download and view the complete annual report

Please find page 56 of the 2011 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 117

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117

Consolidated Statements of Shareholders’ Equity
Pfizer Inc. and Subsidiary Companies
PFIZER INC. SHAREHOLDERS
NON-
CONTROLLING
INTERESTS
TOTAL
SHARE-
HOLDERS’
EQUITY
PREFERRED
STOCK
COMMON
STOCK
ADD’L
PAID-IN
CAPITAL
EMPLOYEE
BENEFIT TRUSTS TREASURY STOCK
RETAINED
EARNINGS
ACCUM.
OTHER
COMP.
INC./
(LOSS)
SHARE-
HOLDERS’
EQUITY
(MILLIONS, EXCEPT
PREFERRED SHARES) SHARES
STATED
VALUE SHARES
PAR
VALUE SHARES
FAIR
VALUE SHARES COST
Balance, January 1, 2009 1,804 $ 73 8,863 $443 $70,283 (24) $(425) (2,117) $(57,391) $ 49,142 $(4,569) $57,556 $ 184 $57,740
Comprehensive income:
Net income 8,635 8,635 8 8,643
Other comprehensive
income, net of tax 5,121 5,121 6 5,127
Total comprehensive income 13,756 14 13,770
Acquisition of Wyeth 1,319 35,733 (12,430) 23,303 330 23,633
Cash dividends declared—
Common stock (4,916) (4,916) (4,916)
Preferred stock (5) (5) (5)
Noncontrolling interests (5) (5)
Stock option transactions 130 — 9 139 139
Employee benefit trust
transactions—net (61) 7 111 50 50
Preferred stock conversions
and redemptions (293) (12) (1) — 3 (10) (10)
Purchase of subsidiary shares
from noncontrolling interests (66) (66) (102) (168)
Other 6 — 212 (2) (28) (1) 23 207 11 218
Balance, December 31, 2009 1,511 61 8,869 443 70,497 (19) (333) (799) (21,632) 40,426 552 90,014 432 90,446
Comprehensive income:
Net income 8,257 8,257 31 8,288
Other comprehensive
income/(loss), net of tax (3,992) (3,992) 5 (3,987)
Total comprehensive income 4,265 36 4,301
Cash dividends declared—
Common stock (5,964) (5,964) (5,964)
Preferred stock (3) (3) (3)
Noncontrolling interests (17) (17)
Stock option transactions 161 1 14 175 175
Purchases of common stock (61) (1,000) (1,000) (1,000)
Employee benefit trust
transactions—net (19) 16 292 273 273
Preferred stock conversions
and redemptions (232) (9) (1) — 2 (8) (8)
Other 7 1 122 2 20 (4) (82) 61 1 62
Balance, December 31, 2010 1,279 52 8,876 444 70,760 — (7) (864) (22,712) 42,716 (3,440) 87,813 452 88,265
Comprehensive income:
Net income 10,009 10,009 42 10,051
Other comprehensive
loss, net of tax (689) (689) (45) (734)
Total comprehensive
income 9,320 (3) 9,317
Cash dividends declared—
Common stock (6,512) (6,512) (6,512)
Preferred stock (3) (3) (3)
Noncontrolling interests (19) (19)
Stock option transactions 312 312 312
Purchases of common stock (459) (9,000) (9,000) (9,000)
Preferred stock conversions
and redemptions (167) (7) (2) — 1 (8) (8)
Other 26 1 353 — 4 (4) (90) — 268 1 269
Balance, December 31, 2011 1,112 $ 45 8,902 $445 $71,423 — $ (3) (1,327) $(31,801) $ 46,210 $(4,129) $82,190 $ 431 $82,621
See Notes to Consolidated Financial Statements, which are an integral part of these statements.
2011 Financial Report 55